![]() |
市場調查報告書
商品編碼
1934308
碘市場-全球產業規模、佔有率、趨勢、機會及預測(依來源、形態、應用、區域及競爭格局分類,2021-2031年)Iodine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Source, By Form, By Application, By Region & Competition, 2021-2031F |
||||||
全球碘市場預計將從 2025 年的 35.8 億美元成長到 2031 年的 53.1 億美元,複合年成長率為 6.79%。
碘是一種重要的非金屬鹵素,在工業、醫藥和農業等眾多領域都發揮著不可或缺的作用。其需求成長主要得益於醫療診斷中造影劑需求的激增以及甲狀腺藥物和帶碘化合物的持續需求。此外,在農業領域,為防止牲畜營養缺乏,強制在飼料中添加碘,確保了碘需求的穩定基礎,使其不易受到市場短期波動的影響。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 35.8億美元 |
| 市場規模:2031年 | 53.1億美元 |
| 複合年成長率:2026-2031年 | 6.79% |
| 成長最快的細分市場 | 人類營養 |
| 最大的市場 | 北美洲 |
然而,由於生產地理集中,市場面臨許多挑戰,供應鏈極易受到供應中斷和價格波動的影響。對有限供應來源的依賴造成了不確定性,並阻礙了買家的長期規劃策略。美國地質調查局的數據顯示,2024年前九個月晶體碘的平均現貨價格徘徊在每公斤69美元左右,凸顯了這些經濟風險。這種波動性表明,金融市場的不穩定性可能會阻礙整體市場擴張。
推動全球碘市場成長的關鍵因素是全球對診斷影像中X光造影劑日益成長的需求。碘是這些藥物中的關鍵造影劑,能夠顯著提高電腦斷層掃描(CT)和X光檢查中器官和血管結構的顯影效果。隨著全球醫療基礎設施的擴展,為應對慢性疾病和老齡化社會,碘基造影劑的使用量正在顯著成長。例如,通用電氣醫療集團(GE Healthcare)於2025年2月發布的「2024會計年度第四季及全年財務表現報告」顯示,其製藥診斷部門的銷售額成長了9%,這主要得益於美國等主要市場對造影劑的持續需求。
同時,碘及其衍生物市場也受惠於醫藥應用領域的不斷拓展,例如甲狀腺治療和消毒劑。除診斷領域外,碘是調節甲狀腺功能的關鍵活性成分,也是優碘消毒劑的重要原料,後者廣泛應用於臨床。儘管其他領域的需求有所波動,但碘及其衍生物的需求仍然強勁。 Iofina公司於2025年5月發布的「2024年全年財務業績」充分體現了這一領域的強勁勢頭,數據顯示碘及其衍生物的銷售額成長了31%,達到1690萬美元。此外,智利化學礦業公司(SQM)在其於2025年6月發布的「2024年年度報告」中宣布,碘及其衍生的收入達到約9.68億美元,進一步印證了這些應用在全球消費中的重要地位。
全球碘市場面臨的主要障礙之一是生產基地的高度地理集中,這導致供應鏈結構僵化且脆弱。全球市場對特定地區的過度依賴缺乏足夠的多元化,難以應對政治變革、物流中斷和營運瓶頸等區域性挑戰。因此,下游產業面臨原料供應風險的增加,阻礙了長期資本投資,並使庫存管理更加複雜。供應持續性的不確定性也使得成本敏感產業的製造商不願意擴大碘的使用量或開發新產品。
這種集中式的生產環境助長了依賴性,並使整個產業面臨嚴重的穩定性問題。根據美國地質調查局(USGS)2024年的數據,智利仍將是全球領先的碘生產國,截至2023年,其碘產量約佔全球總產量的66%。這種不平衡的市場佔有率表明,全球供應平衡高度依賴單一國家的營運可靠性,迫使買家採取防禦性籌資策略而非激進的成長策略。這最終限制了碘產品的廣泛商業性應用,而這對於市場的顯著擴張至關重要。
碘基鈣鈦礦太陽能電池技術的出現,正在傳統工業和製藥用途之外,創造出新的高價值應用。這些先進的光伏技術將碘摻入鈣鈦礦晶體結構中,與標準矽電池相比,實現了更高的能量轉換效率和光吸收效率,從而催生了對高純度碘的特殊需求。該技術正迅速從實驗階段邁向產業化,其效率的不斷突破標誌著其已具備大規模生產的條件。例如,2024年12月,Qcells公司宣布其鈣鈦礦-矽串聯太陽能電池的效率達到了創紀錄的28.6%,這不僅證明了該技術的成熟,也鼓勵了對碘基可可再生能源解決方案的廣泛投資。
同時,該產業正朝著戰略供應鏈多元化方向發展,利用非傳統鹽水資源來應對地理集中帶來的風險。生產商正積極採用先進的回收技術,從油田廢水和其他富含碘的鹽水流中提取碘,從而建立不依賴智利原生蘊藏量的、具有韌性的替代供應基地。這項轉變不僅增強了全球供應安全,也體現了工業產品差異化的循環經濟概念。 Iofina plc 於 2025 年 10 月發布的《2025 年第三季企業趨勢報告》印證了這項轉變。該報告顯示,該公司從其鹽水生產設施中生產了 215.8 公噸結晶質碘化物,比去年同期增加了 32%。
The Global Iodine Market is projected to expand from USD 3.58 Billion in 2025 to USD 5.31 Billion by 2031, registering a CAGR of 6.79%. As a vital nonmetallic halogen, iodine is integral to numerous applications across industrial, medical, and agricultural landscapes, with growth primarily fueled by the surging need for contrast media in medical diagnostics and the continuous demand for thyroid treatments and iodophors. Additionally, the agricultural industry ensures stable consumption levels through the mandatory inclusion of iodine in animal feed to avert nutritional deficiencies in livestock, providing a steady baseline demand independent of fleeting market shifts.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.58 Billion |
| Market Size 2031 | USD 5.31 Billion |
| CAGR 2026-2031 | 6.79% |
| Fastest Growing Segment | Human Nutrition |
| Largest Market | North America |
However, the market contends with significant hurdles due to the intense geographical concentration of production, which exposes the supply chain to potential disruptions and price instability. This dependence on a limited number of sources creates uncertainty that hampers long-term planning strategies for purchasers. Highlighting these economic risks, data from the U.S. Geological Survey indicates that in 2024, the average spot price for iodine crystal hovered around 69 dollars per kilogram during the first nine months of the year, a fluctuation that underscores the financial volatility capable of obstructing broader market development.
Market Driver
The primary catalyst accelerating the Global Iodine Market is the escalating worldwide requirement for X-ray contrast media within diagnostic imaging. Iodine acts as the crucial opacifying element in these pharmaceuticals, drastically improving the visualization of organs and vascular structures during Computed Tomography (CT) and X-ray examinations. As healthcare infrastructures expand globally to manage chronic diseases and aging demographics, the uptake of iodine-based contrast agents has risen substantially; for instance, GE HealthCare's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025 reported a 9 percent growth in their Pharmaceutical Diagnostics segment, attributed largely to the enduring demand for imaging agents in major markets like the United States.
Concurrently, the market is bolstered by broadening pharmaceutical applications, specifically regarding thyroid therapies and antiseptic preparations. Beyond diagnostics, iodine remains a vital active component for regulating thyroid health and producing povidone-iodine disinfectants that are ubiquitous in clinical environments, ensuring resilient demand for iodine derivatives despite fluctuations in other sectors. This segment's strength is highlighted by Iofina plc's '2024 Full Year Results' released in May 2025, which showed a 31 percent increase in iodine derivative sales to 16.9 million dollars, while Sociedad Quimica y Minera de Chile (SQM) reported in their June 2025 'Annual Report 2024' that iodine and derivatives revenues hit approximately 968 million dollars, confirming the essential role of these applications in global consumption.
Market Challenge
A major obstacle impeding the Global Iodine Market is the dense geographical concentration of production, which results in a rigid and susceptible supply chain architecture. Because the global market relies heavily on a few specific regions, it lacks the diversification needed to buffer against localized issues such as political changes, logistical failures, or operational bottlenecks. As a result, downstream industries face heightened risks regarding material availability, which deters long-term capital investment and complicates inventory control, leading manufacturers in cost-conscious sectors to hesitate in expanding usage or developing new products when supply continuity remains uncertain.
This centralized production environment fosters a dependency that subjects the entire industry to serious stability concerns. According to the U.S. Geological Survey in 2024, Chile remained the dominant global producer, responsible for roughly 66 percent of the world's iodine output in 2023. Such a lopsided market share suggests that global supply equilibrium is heavily dependent on the operational reliability of a single nation, compelling buyers to adopt defensive procurement tactics rather than pursuing aggressive growth strategies, which ultimately restricts the broader commercial adoption necessary for substantial market expansion.
Market Trends
The emergence of Iodine-Based Perovskite Solar Cell technology is generating a new, high-value application avenue that surpasses traditional industrial and pharmaceutical uses. These advanced photovoltaics employ iodine-infused perovskite crystal structures to attain superior energy conversion and light absorption efficiencies relative to standard silicon cells, creating niche demand for high-purity iodine grades. This technology is swiftly moving from experimental concepts to industrial reality, marked by efficiency milestones that indicate readiness for large-scale manufacturing; for example, Qcells announced in December 2024 that they achieved a world record efficiency of 28.6 percent for a perovskite-silicon tandem solar cell, demonstrating technical maturity that invites wider investment in iodine-reliant renewable energy solutions.
At the same time, the industry is witnessing a trend toward the Strategic Diversification of Supply Chains through non-traditional brine sources to counteract the dangers of geographical centralization. Producers are increasingly deploying advanced recovery methods to extract iodine from oilfield produced water and other rich brine streams, creating resilient alternative supply centers independent of the dominant Chilean reserves. This evolution not only strengthens global supply security but also embraces circular economy concepts by utilizing industrial byproducts, a shift illustrated by Iofina plc's 'Q3 2025 Corporate Update' from October 2025, which reported the production of 215.8 metric tonnes of crystalline iodide from brine-based facilities, marking a 32 percent rise over the same period the prior year.
Report Scope
In this report, the Global Iodine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Iodine Market.
Global Iodine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: